548 Results

People

  1. Rossi
    Rossi
  2. Dee
    Dee
  3. Marghoob
    Marghoob
  4. Dogan
    Dogan
  5. Dusza
    Dusza
  6. Giralt
    Giralt
  7. Perales
    Perales
  8. Marchetti
    Marchetti
  9. Nehal
    Nehal
  10. Salles
    Salles

Groups

  1. Department of Medicine (301)
  2. Hematologic Malignancies, Division of (169)
  3. Center for Hematologic Malignancies (151)
  4. Sloan Kettering Institute Postdocs (133)
  5. Survivorship Research (132)
  6. Division of Subspecialty Medicine (121)
  7. Population Sciences Research Program (116)
  8. GSK Faculty (96)
  9. Dermatology Service (87)
  10. Dermatology (86)
  1. "Research letter"
Formats
  1. Research Letter (548)
Groups
  1. Department of Medicine (301)
  2. Hematologic Malignancies, Division of (169)
  3. Center for Hematologic Malignancies (151)
  4. Sloan Kettering Institute Postdocs (133)
  5. Survivorship Research (132)
  6. Division of Subspecialty Medicine (121)

More Groups

People
  1. Anthony Rossi (23)
  2. Edward Christopher Dee (21)
  3. Ashfaq Marghoob (19)
  4. Ahmet Dogan (18)
  5. Michael Marchetti (18)
  6. Miguel-Angel Perales (17)

More People

Years
  1. 2025 (42)
  2. 2024 (89)
  3. 2023 (101)
  4. 2022 (82)
  5. 2021 (91)
  6. 2020 (95)

More Years

Publications
  1. Journal of the American Academy of Dermatology (46)
  2. Blood Advances (31)
  3. Haematologica (25)
  4. Leukemia (25)
  5. Bone Marrow Transplantation (18)
  6. American Journal of Hematology (17)

More Publications

Publishers
  1. Nature Publishing Group (97)
  2. Mosby Elsevier (49)
  3. American Medical Association (45)
  4. American Society of Hematology (44)
  5. Wiley Blackwell (34)
  6. Elsevier Inc. (29)

More Publishers

Results (548)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DNA methylation in circulating leukocytes is a novel biomarker in multiple myeloma
    Research Letter

    D’Souza, A.; Brazauskas, R.; Teng, B. Q.; Yun, G.; Uttley, H.; Dong, J.; Dwinell, M. B.; Pasquini, M. C.; Giralt, S.; Landau, H.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) (OVHIPEC-2)
    Research Letter

    Gregory, S. N.; Ryan, C. E.; Hernandez, J. M.; Sonke, G. S.; Aronson, S. L.; Zivanovic, O.; van Driel, W. J.; on behalf of the OVHIPEC-2 Study Group
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Association of structural fires in New York City with inequities in safe heating for immigrant communities
    Research Letter

    Stanton, E.; Biedry, J.; Rochlin, D.; Sheckter, C. C.
    JAMA Network Open (2023)

    Fulltext@MSK | Save
  • Clonal hematopoiesis in diffuse large B-cell lymphoma: Clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm
    Research Letter

    Liu, Y.; Derkach, A.; Lewis, N.; Zhu, M.; Zhang, Y.; Arcila, M.; Salles, G.; Dogan, A.; Xiao, W.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia
    Research Letter

    Przespolewski, A.; Goldberg, A. D.; Talati, C.; Fazal, S.; Vachhani, P.; Sanikommu, S. R.; Thota, S.; Waksal, J.; Ball, B.; Famulare, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distribution of skin diseases among patients using methamphetamine
    Research Letter

    Bang, A. S.; Zakaria, A.; Williams, J. C.; Amerson, E. H.; Leslie, K. S.
    Journal of the American Academy of Dermatology (2023)

    Fulltext@MSK | Save
  • Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition
    Research Letter

    Jacoby, T. V.; Shah, N.; Asdourian, M. S.; Thompson, L. L.; Otto, T. S.; LeBoeuf, N. R.; Semenov, Y.; Dee, E. C.; Reynolds, K. L.; Chen, S. T.
    Journal of the American Academy of Dermatology (2023)

    Fulltext@MSK | Save
  • Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: Part 3 of the open-label, multicenter, phase 1b PAVO study
    Research Letter

    Nahi, H.; Usmani, S. Z.; Mateos, M. V.; van de Donk, N. W. C. J.; Oriol, A.; Plesner, T.; Bandyopadhyay, N.; Hellemans, P.; Tromp, B.; Nnane, I.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Activating STAT5B mutations can cause both primary hypereosinophilia and lymphocyte-variant hypereosinophilia
    Research Letter

    Umrau, K.; Naganuma, K.; Gao, Q.; Dogan, A.; Kizaki, M.; Roshal, M.; Liu, Y.; Yabe, M.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma
    Research Letter

    Gardenswartz, A.; Mehta, B.; El-Mallawany, N. K.; van de Ven, C.; Hochberg, J.; Flower, A.; Morris, E.; Harrison, L.; Chu, Y.; Basso, J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save